ZHONGHONG PULIN MEDICAL PRODUCTS CO., LTD. Financials Zhonghong Pulin Medical Products Co., Ltd.
Equities
300981
CNE100004KR0
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.53 CNY | -1.26% |
|
+3.55% | -21.79% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 13,324 | 5,634 | 6,248 |
| Enterprise Value (EV) 1 | 8,932 | 2,048 | 3,817 |
| P/E ratio | 5.21 x | 85.4 x | -47.1 x |
| Yield | 5.63% | 3.73% | 3.12% |
| Capitalization / Revenue | 2.71 x | 3.58 x | 2.97 x |
| EV / Revenue | 1.82 x | 1.3 x | 1.81 x |
| EV / EBITDA | 3.22 x | -604 x | 153 x |
| EV / FCF | 20.8 x | -16.4 x | -14.4 x |
| FCF Yield | 4.8% | -6.11% | -6.93% |
| Price to Book | 2.03 x | 0.92 x | 1.08 x |
| Nbr of stocks (in thousands) | 390,008 | 390,008 | 390,008 |
| Reference price 2 | 34.16 | 14.45 | 16.02 |
| Announcement Date | 4/27/22 | 4/24/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 967.5 | 1,171 | 4,778 | 4,909 | 1,573 | 2,105 |
| EBITDA 1 | 113.2 | 166.2 | 3,326 | 2,772 | -3.391 | 24.89 |
| EBIT 1 | 77.02 | 119.1 | 3,267 | 2,693 | -147.2 | -174.2 |
| Operating Margin | 7.96% | 10.17% | 68.36% | 54.86% | -9.36% | -8.27% |
| Earnings before Tax (EBT) 1 | 70.33 | 105.8 | 3,192 | 2,784 | 51.27 | -137.7 |
| Net income 1 | 56.67 | 89.27 | 2,664 | 2,342 | 66.92 | -130.9 |
| Net margin | 5.86% | 7.62% | 55.74% | 47.7% | 4.26% | -6.22% |
| EPS 2 | 0.1923 | 0.3034 | 9.107 | 6.551 | 0.1692 | -0.3400 |
| Free Cash Flow 1 | -147.5 | -53.13 | 1,655 | 429 | -125.1 | -264.6 |
| FCF margin | -15.24% | -4.54% | 34.63% | 8.74% | -7.95% | -12.57% |
| FCF Conversion (EBITDA) | - | - | 49.76% | 15.48% | - | - |
| FCF Conversion (Net income) | - | - | 62.13% | 18.32% | - | - |
| Dividend per Share | - | 0.2564 | 1.709 | 1.923 | 0.5385 | 0.5000 |
| Announcement Date | 3/30/21 | 3/30/21 | 4/25/21 | 4/27/22 | 4/24/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 269 | 258 | - | - | - | - |
| Net Cash position 1 | - | - | 1,450 | 4,392 | 3,586 | 2,431 |
| Leverage (Debt/EBITDA) | 2.374 x | 1.552 x | - | - | - | - |
| Free Cash Flow 1 | -147 | -53.1 | 1,655 | 429 | -125 | -265 |
| ROE (net income / shareholders' equity) | 16% | 21.7% | 176% | 51.4% | 1.06% | -2.12% |
| ROA (Net income/ Total Assets) | 5.76% | 7.26% | 86% | 31.1% | -1.32% | -1.57% |
| Assets 1 | 984.6 | 1,230 | 3,098 | 7,530 | -5,081 | 8,339 |
| Book Value Per Share 2 | 1.280 | 1.600 | 8.740 | 16.80 | 15.70 | 14.80 |
| Cash Flow per Share 2 | 0.1100 | 0.2400 | 4.020 | 2.170 | 1.240 | 1.990 |
| Capex 1 | 203 | 150 | 429 | 979 | 208 | 103 |
| Capex / Sales | 20.99% | 12.85% | 8.99% | 19.93% | 13.2% | 4.9% |
| Announcement Date | 3/30/21 | 3/30/21 | 4/25/21 | 4/27/22 | 4/24/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -21.79% | 674M | |
| +9.72% | 27.43B | |
| -29.70% | 3.18B | |
| -16.08% | 2.53B | |
| +19.05% | 2.49B | |
| +11.11% | 2.16B | |
| -4.24% | 2.03B | |
| +5.56% | 1.61B | |
| +3.25% | 1.31B | |
| +29.73% | 1.29B |
- Stock Market
- Equities
- 300981 Stock
- Financials Zhonghong Pulin Medical Products Co., Ltd.